The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness

Science Immunology

Volumn 1, Issue 6, 2016, Pages

  Wu, Tuoqi ^a   Ji, Yun ^b   Ashley Moseman, E ^c   Xu, Haifeng C ^d   Manglani, Monica ^c   Kirby, Martha ^a   Anderson, Stacie M ^a   Handon, Robin ^a   Kenyon, Elizabeth ^c   Elkahloun, Abdel ^a   Wu, Weiwei ^a   Lang, Philipp A ^d   Gattinoni, Luca ^b   McGavern, Dorian B ^c   Schwartzberg, Pamela L ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85014738071     PISSN: None     EISSN: 24709468     Source Type: Journal    
DOI: 10.1126/sciimmunol.aai8593     Document Type: Article

References (49)

1. R. Ahmed, D. Gray, Immunological memory and protective immunity: Understanding their relation. Science 272, 54–60 (1996).
2. + T cell differentiation during viral infection. Immunity 27, 393–405 (2007).
3. E. J. Wherry, M. Kurachi, Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15, 486–499 (2015).
4. E. J. Wherry, T cell exhaustion. Nat. Immunol. 12, 492–499 (2011).
5. J. M. Angelosanto, S. D. Blackburn, A. Crawford, E. J. Wherry, Progressive loss of memory T cell potential and commitment to exhaustion during chronic viral infection. J. Virol. 86, 8161–8170 (2012).
6. D. L. Barber, E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, R. Ahmed, Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682–687 (2006).
7. + T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 10, 29–37 (2009).
8. T. L. Walunas, D. J. Lenschow, C. Y. Bakker, P. S. Linsley, G. J. Freeman, J. M. Green, C. B. Thompson, J. A. Bluestone, CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405–413 (1994).
9. G. J. Freeman, A. J. Long, Y. Iwai, K. Bourque, T. Chernova, H. Nishimura, L. J. Fitz, N. Malenkovich, T. Okazaki, M. C. Byrne, H. F. Horton, L. Fouser, L. Carter, V. Ling, M. R. Bowman, B. M. Carreno, M. Collins, C. R. Wood, T. Honjo, Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192, 1027–1034 (2000).
10. C. Blank, I. Brown, A. C. Peterson, M. Spiotto, Y. Iwai, T. Honjo, T. F. Gajewski, PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells. Cancer Res. 64, 1140–1145 (2004).
11. D. M. Pardoll, The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252–264 (2012).
12. H.-T. Jin, A. C. Anderson, W. G. Tan, E. E. West, S.-J. Ha, K. Araki, G. J. Freeman, V. K. Kuchroo, R. Ahmed, Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc. Natl. Acad. Sci. U.S.A. 107, 14733–14738 (2010).
13. K. Sakuishi, L. Apetoh, J. M. Sullivan, B. R. Blazar, V. K. Kuchroo, A. C. Anderson, Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J. Exp. Med. 207, 2187–2194 (2010).
14. D. G. Brooks, M. J. Trifilo, K. H. Edelmann, L. Teyton, D. B. McGavern, M. B. A. Oldstone, Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12, 1301–1309 (2006).
15. J. R. Teijaro, C. Ng, A. M. Lee, B. M. Sullivan, K. C. F. Sheehan, M. Welch, R. D. Schreiber, J. C. de la Torre, M. B. A. Oldstone, Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340, 207–211 (2013).
16. E. B. Wilson, D. H. Yamada, H. Elsaesser, J. Herskovitz, J. Deng, G. Cheng, B. J. Aronow, C. L. Karp, D. G. Brooks, Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 340, 202–207 (2013).
17. I. Osokine, L. M. Snell, C. R. Cunningham, D. H. Yamada, E. B. Wilson, H. J. Elsaesser, J. C. de la Torre, D. Brooks, Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection. Proc. Natl. Acad. Sci. U.S.A. 111, 7409–7414 (2014).
18. S. D. Blackburn, H. Shin, G. J. Freeman, E. J. Wherry, Selective expansion of a subset of exhausted CD8 T cells by aPD-L1 blockade. Proc. Natl. Acad. Sci. U.S.A. 105, 15016–15021 (2008).
19. + T cells cooperate to contain chronic viral infection. Science 338, 1220–1225 (2012).
20. + T cells depend on T cell factor 1. Immunity 33, 229–240 (2010).
21. T. Wu, H. M. Shin, E. A. Moseman, Y. Ji, B. Huang, C. Harly, J. M. Sen, L. J. Berg, L. Gattinoni, D. B. McGavern, P. L. Schwartzberg, TCF1 is required for the T follicular helper cell response to viral infection. Cell Rep. 12, 2099–2110 (2015).
22. FH differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6. Nat. Immunol. 16, 980–990 (2015).
23. FH cells during acute viral infection. Nat. Immunol. 16, 991–999 (2015).
24. L. M. Fahey, E. B. Wilson, H. Elsaesser, C. D. Fistonich, D. B. McGavern, D. G. Brooks, Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells. J. Exp. Med. 208, 987–999 (2011).
25. E. J. Wherry, J. N. Blattman, K. Murali-Krishna, R. van der Most, R. Ahmed, Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77, 4911–4927 (2003).
26. + memory stem cells. Nat. Med. 15, 808–813 (2009).
27. G. Jeannet, C. Boudousquié, N. Gardiol, J. Kang, J. Huelsken, W. Held, Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memory. Proc. Natl. Acad. Sci. U.S.A. 107, 9777–9782 (2010).
28. + T cell exhaustion during chronic viral infection. Immunity 31, 309–320 (2009).
29. T. Boettler, F. Moeckel, Y. Cheng, M. Heeg, S. Salek-Ardakani, S. Crotty, M. Croft, M. G. von Herrath, OX40 facilitates control of a persistent virus infection. PLOS Pathog. 8, e1002913 (2012).
30. + T cells to maintain tumor tolerance. J. Exp. Med. 212, 2095–2113 (2015).
31. H. Pircher, K. Bürki, R. Lang, H. Hengartner, R. M. Zinkernagel, Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342, 559–561 (1989).
32. + T cells. J. Immunol. 175, 4627–4634 (2005).
33. R. J. Johnston, A. C. Poholek, D. DiToro, I. Yusuf, D. Eto, B. Barnett, A. L. Dent, J. Craft, S. Crotty, Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325, 1006–1010 (2009).
34. R. I. Nurieva, Y. Chung, G. J. Martinez, X. O. Yang, S. Tanaka, T. D. Matskevitch, Y.-H. Wang, C. Dong, Bcl6 mediates the development of T follicular helper cells. Science 325, 1001–1005 (2009).
35. C. Tunyaplin, A. L. Shaffer, C. D. Angelin-Duclos, X. Yu, L. M. Staudt, K. L. Calame, Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation. J. Immunol. 173, 1158–1165 (2004).
36. D. Lara-Astiaso, A. Weiner, E. Lorenzo-Vivas, I. Zaretsky, D. A. Jaitin, E. David, H. Keren-Shaul, A. Mildner, D. Winter, S. Jung, N. Friedman, I. Amit, Chromatin state dynamics during blood formation. Science 345, 943–949 (2014).
37. J. P. Ray, H. D. Marshall, B. J. Laidlaw, M. M. Staron, S. M. Kaech, J. Craft, Transcription factor STAT3 and type I interferons are corepressive insulators for differentiation of follicular helper and T helper 1 cells. Immunity 40, 367–377 (2014).
38. + T cells from NK cell cytotoxicity. Immunity 40, 949–960 (2014).
39. J. Crouse, G. Bedenikovic, M. Wiesel, M. Ibberson, I. Xenarios, D. Von Laer, U. Kalinke, E. Vivier, S. Jonjic, A. Oxenius, Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1. Immunity 40, 961–973 (2014).
40. M. Pepper, A. J. Pagán, B. Z. Igyártó, J. J. Taylor, M. K. Jenkins, Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells. Immunity 35, 583–595 (2011).
41. A. Ballesteros-Tato, B. León, B. A. Graf, A. Moquin, P. S. Adams, F. E. Lund, T. D. Randall, Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation. Immunity 36, 847–856 (2012).
42. FH cell differentiation. J. Exp. Med. 209, 243–250 (2012).
43. + T cells curtail chronic viral infection. Nature 537, 412–428 (2016).
44. + T cells that provide the proliferative burst after PD-1 therapy. Nature 537, 417–421 (2016).
45. + T cells sustain the immune response to chronic viral infections. Immunity 45, 415–427 (2016).
46. + follicular cytotoxic T cells control viral infection in B cell follicles. Nat. Immunol. 17, 1187–1196 (2016).
47. D. R. Fooksman, M. C. Nussenzweig, M. L. Dustin, Myeloid cells limit production of antibody-secreting cells after immunization in the lymph node. J. Immunol. 192, 1004–1012 (2014).
48. R. Ahmed, A. Salmi, L. D. Butler, J. M. Chiller, M. B. Oldstone, Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160, 521–540 (1984).
49. FH cell responses during viral infection. J. Immunol. 195, 2515–2519 (2015).